|
|
To explore the molecular and cellular effects of transient DUX4 expression in skeletal muscle |
| 1R01AR081228-01 |
|
NIAMS |
2022 |
|
|
Investigating how Mylpf-regulated sarcomere formation influences limb skeletal development |
| 1R15AR081019-01 |
|
NIAMS |
2022 |
|
|
JAK Inhibition in Down Syndrome |
| 4R33AR077495-03 |
|
NIAMS |
2022 |
|
|
Probing the activity of DUX4 in FSHD |
| 5R01AR055685-13 |
|
NIAMS |
2022 |
|
|
Mechanisms of DUX4 mediated FSHD pathology |
| 5R01AR062587-09 |
|
NIAMS |
2022 |
|
|
The Skeleton of Lateral Meningocele Syndrome |
| 5R01AR072987-04 |
|
NIAMS |
2022 |
|
|
Rheumatoid Arthritis and Autism Spectrum Disorder |
| 5R01AR075812-04 |
|
NIAMS |
2022 |
|
|
Mechanisms of NAD+ action during muscle development and homeostasis in a zebrafish dystroglycanopathy model |
| 5R01AR075836-04 |
|
NIAMS |
2022 |
|
|
Novel MYBPC1 mutations cosegregate with a myopathy associated with muscle weakness, hypotonia and tremor |
| 5R01AR076373-03 |
|
NIAMS |
2022 |
|
|
Addressing knowledge gaps by multi-level research design to optimize clinical trial development in order to reduce fracture burden for adults with neurodevelopmental disabilities |
| 5R01AR076994-02 |
|
NIAMS |
2022 |
